Healthcare Fraud Analytics Market Size, Growth and Forecast 2032

Healthcare Fraud Analytics market size was valued at USD 2.92 billion in 2024 and is projected to reach USD 16.4 billion by 2032.

By Geography (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); By Application (Insurance claims review, Pharmacy billing issue, Payment integrity, Other applications); By Solution Type (Descriptive analytics, Predictive analytics, Prescriptive analytics); By Deployment Mode (Cloud-based, On-premises)

SKU: CR3382Report Pages: 250Category: HealthcareReport Format: PDF, ExcelLast Updated: Dec 4Author: Dr. Pankaj SharmaReviewed by: Deepti AgrawalPreferred on

Market Report Metrics

Revenue, 2024 -
USD 2.92 billion
Forecast Year -
2032
CAGR (2024–2032)
24.1%
Report Coverage
Global

Market Overview

Healthcare Fraud Analytics Market size was valued at USD 2.92 billion in 2024 and is anticipated to reach USD 16.4 billion by 2032, at a CAGR of 24.1% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Healthcare Fraud Analytics Market Size 2024 USD 2.92 billion
Healthcare Fraud Analytics Market, CAGR 24.1%
Healthcare Fraud Analytics Market Size 2032 USD 16.4 billion
 

The Healthcare Fraud Analytics Market includes key players such as Conduent, Inc, SAS Institute, Inc, Kyndryl, Optum, Inc, Wipro Limited, Cotiviti, Inc, EXL Service Holdings, Inc, HCL Technologies Limited, IBM, and DXC Technology. These companies strengthen their position through AI-based fraud detection tools, cloud analytics platforms, and integrated payment integrity solutions that support real-time claim monitoring. North America remained the leading region in 2024 with about 46% share due to strict regulatory oversight, strong digital adoption, and early deployment of advanced analytics across insurance networks. Europe held around 28% share, supported by national health systems adopting predictive fraud detection and compliance-focused technologies.

Healthcare Fraud Analytics Market size

Market Insights

  • The Healthcare Fraud Analytics Market was valued at USD 2.92 billion in 2024 and is projected to reach USD 16.4 billion by 2032, growing at a CAGR of 24.1%.
  • Strong demand rises as insurers and hospitals adopt analytics to reduce rising fraudulent claims, with insurance claims review holding about 52% share in 2024.
  • AI-driven detection, cloud migration, and real-time monitoring remain key trends as organizations strengthen compliance and reduce payment leakages.
  • Competition grows as major vendors enhance predictive models and integrated fraud-prevention platforms, focusing on accuracy, automation, and scalable deployment.
  • North America led the market with about 46% share in 2024, followed by Europe with 28%, while cloud-based deployment held nearly 58% share due to faster scaling and lower infrastructure costs.

Market Segmentation Analysis:

By Solution Type

Descriptive analytics led the solution type segment in 2024 with about 46% share of the Healthcare Fraud Analytics Market. Hospitals and insurers used descriptive models to detect suspicious billing trends and flag abnormal claim patterns in real time. Growth came from the rising volume of digital health records and the need for clear insights into fraud-prone activities. Predictive analytics also expanded as payers adopted machine-learning tools to forecast fraud risks, while prescriptive analytics gained attention for guiding corrective actions.

  • For instance, SAS fraud analytics supports Odisha’s BSKY (Biju Swasthya Kalyan Yojana) scheme, which provides health coverage to over 3.56 crore (35.6 million) cardholders across a network of 9,509 hospitals

By Deployment Mode

Cloud-based deployment dominated this segment in 2024 with nearly 58% share of the Healthcare Fraud Analytics Market. Healthcare providers preferred cloud platforms because they offer faster scaling, stronger integration with claims systems, and lower upfront infrastructure costs. Adoption increased as insurers shifted to SaaS-based fraud detection tools that support real-time monitoring and secure data sharing across networks. On-premises deployment remained relevant for organizations with strict internal data-control policies but grew at a slower pace.

  • For instance, Amazon Web Services supports healthcare workloads for 19 of the top 20 global pharmaceutical companies using its cloud platform.

By Application

Insurance claims review held the leading position in 2024 with about 52% share of the Healthcare Fraud Analytics Market. Both prepayment and postpayment review systems gained traction as insurers worked to reduce false claims and identify coding errors before reimbursement. Demand rose due to strict regulatory oversight and rising healthcare costs, which pushed payers to adopt automated review tools. Pharmacy billing issue detection and payment integrity solutions also grew as fraud involving drug claims and overbilling became more common across healthcare networks.

Key Growth Drivers

Rising healthcare fraud cases

Healthcare fraud cases surged across insurance and provider networks, pushing organizations to adopt advanced analytics tools. Payers sought faster ways to detect abnormal claim behavior and reduce financial losses linked to false billing and identity misuse. Adoption increased as regulatory agencies tightened audit rules and promoted stronger surveillance systems. These conditions positioned fraud analytics as a core requirement for both private and public healthcare programs.

  • For instance, CVS Caremark processed about 2.3 billion pharmacy claims for roughly 108 million members in 2023, highlighting the scale of claims exposed to misuse risk.

Shift toward digital health records

Growing use of electronic health records created large datasets that supported stronger fraud detection. Healthcare providers leveraged analytics to spot mismatched patient information, improper coding, and duplicate claim submissions. The migration to digital platforms allowed real-time monitoring and reduced manual review delays. This shift improved transparency, strengthened compliance, and accelerated the demand for automated fraud analytics tools across hospitals and insurers.

  • For instance, Epic manages electronic records for over 325 million patients and supports massive data exchange across hospitals and clinics through its interoperability network.

Expansion of AI and machine learning

AI and machine learning models improved the accuracy of fraud detection by identifying hidden billing patterns that traditional systems often missed. Health insurers adopted ML-based scoring systems to flag high-risk claims and reduce payment errors. Automated decision models helped shorten investigation time and support proactive fraud prevention. These capabilities made AI-driven analytics a major growth catalyst in the market.

Growth of cloud-based analytics

Cloud platforms gained strong traction as payers and providers shifted from legacy systems to scalable fraud detection tools. Cloud deployment reduced setup costs and enabled faster integration with claims platforms. Real-time dashboards supported better risk classification and data sharing among stakeholders. This trend opened major opportunities for vendors offering secure, flexible, and AI-integrated cloud analytics solutions.

  • For instance, Salesforce Health Cloud is in active use by hundreds of healthcare and life-science organizations worldwide-over 630 customers in total-supporting cloud-based patient engagement, care coordination, and data analytics.

Increasing focus on payment integrity

Healthcare providers placed stronger focus on payment accuracy due to rising reimbursement pressures. Analytics tools that validated claim submissions, verified coding accuracy, and monitored provider behavior saw rapid adoption. Payers used integrated platforms to cut wasteful spending and ensure compliance with reimbursement guidelines. This trend created new opportunities for vendors offering unified payment integrity and fraud prevention technology.

  • For instance, Cotiviti’s payment accuracy suite can cut claim review cycles from over 90 days to fewer than five days for health plans.

Growing adoption in pharmacy fraud detection

Rising misuse of drug claims and escalating prescription costs boosted demand for analytics in pharmacy billing oversight. Systems designed to detect unusual refill patterns, controlled-substance misuse, and false pharmacy submissions gained deeper use. Health plans viewed pharmacy fraud analytics as a high-value tool to reduce losses and manage formulary spending. This shift provided a growing opportunity for specialized analytics providers.

Key Challenges

Data privacy and security concerns

Healthcare data remains highly sensitive, and fraud analytics platforms require access to large datasets for effective performance. This creates concerns related to data sharing, cross-network access, and compliance with privacy laws. Providers and insurers must balance strong analytics adoption with strict protection of patient records. These constraints slow deployment and increase the need for secure, compliant infrastructure.

Complexity of integrating multiple data sources

Healthcare networks operate with diverse systems, coding standards, and claim formats, making data integration difficult. Fraud analytics tools need consistent and high-quality inputs to deliver accurate detection. Merging datasets from hospitals, insurers, pharmacies, and third-party administrators can create technical challenges. This complexity delays implementation and raises operational costs for healthcare organizations adopting analytics platforms.

Regional Analysis

North America

North America held the largest share of the Healthcare Fraud Analytics Market in 2024 with about 46%. Strong adoption came from strict regulatory oversight, advanced insurance systems, and high digital integration across hospitals and payers. The United States led growth due to rising fraudulent claim cases and rapid use of AI-based detection tools by major insurers. Canada also expanded its analytics adoption as health agencies strengthened audit processes. Demand increased as healthcare networks focused on reducing wasteful spending and improving payment integrity. Broad deployment of cloud analytics further supported the region’s strong position.

Europe

Europe accounted for nearly 28% share of the Healthcare Fraud Analytics Market in 2024. Growth accelerated as national health systems adopted predictive analytics to identify improper billing and coding errors. Countries such as Germany, the United Kingdom, and France strengthened fraud prevention frameworks and encouraged digital monitoring across insurance bodies. The region saw rising interest in cloud-based solutions as organizations sought flexible platforms with strong compliance features. Increased cross-border healthcare activities also pushed insurers to invest in better fraud detection tools. These factors supported consistent adoption across public and private healthcare networks.

Asia Pacific

Asia Pacific captured about 17% share of the Healthcare Fraud Analytics Market in 2024 and showed high growth potential. Expanding health insurance coverage and rapid digitalization in countries like China, India, and Japan boosted adoption. Governments invested in advanced analytics to manage rising claim volumes and reduce fraud-related losses. Hospitals and insurers used AI-enabled platforms to detect unusual billing behaviors and strengthen compliance. Increasing cloud usage improved access to scalable fraud detection systems. Growing private healthcare spending and rising fraud awareness further supported the region’s upward trajectory.

Latin America

Latin America held around 6% share of the Healthcare Fraud Analytics Market in 2024. Growth was supported by rising fraudulent claim activity and the need for stronger oversight in public insurance programs. Countries such as Brazil and Mexico adopted digital fraud monitoring platforms to improve audit performance and reduce monetary losses. The region saw increasing deployment of cloud-based analytics as organizations sought cost-effective detection tools. Limited digital infrastructure in some nations slowed progress, yet expanding insurance markets created steady demand for analytics-driven fraud prevention.

Middle East and Africa

The Middle East and Africa accounted for nearly 3% share of the Healthcare Fraud Analytics Market in 2024. Adoption grew as healthcare systems modernized and insurers introduced digital claim processing platforms. Governments in the Gulf region invested in analytics to strengthen regulatory compliance and detect improper billing. Africa showed gradual progress with expanding health insurance programs and rising digital health initiatives. Market growth remained moderate due to uneven technology infrastructure, yet increasing awareness of fraud and waste encouraged more organizations to adopt analytical tools for stronger payment integrity.

Market Segmentations:

By Solution Type

  • Descriptive analytics
  • Prescriptive analytics
  • Predictive analytics

By Deployment Mode

  • On-premises
  • Cloud-based

By Application

  • Insurance claims review
    • Postpayment review
    • Prepayment review
  • Pharmacy billing issue
  • Payment integrity
  • Other applications

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

The Healthcare Fraud Analytics Market features major players such as Conduent, Inc, SAS Institute, Inc, Kyndryl, Optum, Inc, Wipro Limited, Cotiviti, Inc, EXL Service Holdings, Inc, HCL Technologies Limited, IBM, and DXC Technology. The competitive landscape reflects strong investment in AI, machine learning, and cloud-based analytics platforms designed to improve real-time fraud detection and reduce claim-related leakages. Vendors focus on developing integrated solutions that support payment integrity, automated claim review, and risk scoring. Partnerships with insurers, government health agencies, and large hospital networks help expand market reach and strengthen product adoption. Many companies enhance their offerings through advanced data integration capabilities, predictive modeling, and secure cloud infrastructure to meet regulatory requirements. The rising demand for scalable and automated fraud detection platforms continues to intensify competition, encouraging players to differentiate through faster processing, higher detection accuracy, and improved interoperability with existing health IT systems.

Key Player Analysis

Recent Developments

  • In 2025, Cotiviti, Inc. showcased their advanced solution, 360 Pattern Review™, at the National Health Care Anti-Fraud Association (NHCAA) Annual Training Conference.
  • In 2025, DXC Technology announced it had been named to the prestigious Forbes America's Best Management Consulting Firms 2025 list for the third consecutive year.
  • In 2023, Kyndryl has announced the deployment of a next generation of insurance fraud analytics with comprehensive technology solution for ClaimSearch Israel Ltd.

Report Coverage

The research report offers an in-depth analysis based on Solution Type, Deployment Mode, Application and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. Adoption of AI-driven fraud detection models will grow across insurers and hospitals.
  2. Cloud-based analytics platforms will expand as organizations shift from legacy systems.
  3. Real-time claim monitoring will become standard to reduce payment delays and fraud losses.
  4. Predictive analytics will gain deeper use to identify high-risk patterns earlier in the claims cycle.
  5. Pharmacy fraud detection tools will rise due to increasing misuse of drug billing.
  6. Integration of analytics with electronic health records will improve data accuracy and insight quality.
  7. Payment integrity platforms will merge with fraud detection systems for unified oversight.
  8. Regulatory pressure will intensify, pushing providers to invest in advanced fraud prevention tools.
  9. Machine-learning-based automation will reduce manual review workloads for payers.
  10. Expansion of digital health ecosystems will create larger datasets that enhance fraud detection accuracy.
Healthcare Fraud Analytics Market Size, Growth and Forecast 2032
Report Attribute Details
Details
Historical Period
-
Base Year
2024
Forecast Period
2024–2032
Healthcare Fraud Analytics Size 2024
USD 2.92 billion
Healthcare Fraud Analytics CAGR
24.1%
Healthcare Fraud Analytics Size 2032
USD 16.4 billion

Request a Free Sample

Fill in your details and we'll send you a free sample report.

  • Sample data tables & charts
  • Research methodology

Market Dynamics

Rising healthcare fraud cases

The surge in fraudulent activities across insurance and provider networks is compelling organizations to adopt advanced analytics tools to detect abnormal claim behavior and reduce financial losses from false billing and identity misuse.

Shift toward digital health records

The widespread adoption of electronic health records has created large, integrated datasets, enabling more effective fraud detection by allowing analytics platforms to spot mismatched patient information, improper coding, and duplicate claims in real time.

Expansion of AI and machine learning

AI and machine learning technologies are improving the accuracy and speed of fraud detection by identifying hidden billing patterns and automating risk scoring, which helps insurers proactively prevent and investigate fraud.

Growth of cloud-based analytics

Cloud-based deployment is accelerating due to its scalability, lower infrastructure costs, and ability to support real-time monitoring and integration with claims systems, making advanced fraud analytics more accessible to healthcare organizations.

Increasing focus on payment integrity

Rising reimbursement pressures and regulatory scrutiny are driving healthcare providers and payers to adopt analytics tools that validate claims, verify coding accuracy, and monitor provider behavior, ensuring compliance and reducing wasteful spending.

Need a Custom Version of This Report?

Tailor the scope, geography, or segments to your exact requirements.

  • Custom geography or segment scope
  • Direct access to our analyst team

Frequently Asked Questions

What is the current market size for Healthcare Fraud Analytics Market, and what is its projected size in 2032?
The market stood at USD 2.92 billion in 2024 and is projected to reach USD 16.4 billion by 2032.
At what Compound Annual Growth Rate is the Healthcare Fraud Analytics Market projected to grow between 2025 and 2032?
The market is expected to grow at a CAGR of 24.1% during the forecast period.
Which is the leading region of the market for Healthcare Fraud Analytics?
North America accounted for the most heightened share in the global Healthcare Fraud Analytics market.
What are the key drivers for the growth of the Healthcare Fraud Analytics market?
Rising Instances of Healthcare Fraud, Increasing Healthcare Expenditure, Stringent Regulatory Requirements, Advancements in Analytics Technologies drive the Healthcare Fraud Analytics market.
Which is the major segment in the Healthcare Fraud Analytics market by application?
The Insurance Claims Review segment had a major share in the global market.

Table of Content

Chapter 1 Market Segmentation

  • 1.1 Segmentation Framework
    • 1.1.1 Product and Service Classification
    • 1.1.2 Application and End-Use Classification
    • 1.1.3 Technology and Solution Classification
    • 1.1.4 Customer and Distribution Channel Classification
    • 1.1.5 Geographic Segmentation
    • 1.1.6 Market Segment Definitions and Boundaries
  • 1.2 By Application
    • 1.2.1 Insurance claims review
    • 1.2.2 Pharmacy billing issue
    • 1.2.3 Payment integrity
    • 1.2.4 Other applications
  • 1.3 By Solution Type
    • 1.3.1 Descriptive analytics
    • 1.3.2 Predictive analytics
    • 1.3.3 Prescriptive analytics
  • 1.4 By Deployment Mode
    • 1.4.1 Cloud-based
    • 1.4.2 On-premises

Chapter 2 Introduction

  • 2.1 Report Objectives and Scope
  • 2.2 Product Definition and Industry Terminology
  • 2.3 Market Inclusions and Exclusions
  • 2.4 Research Process
    • 2.4.1 Primary Research and Expert Interviews
    • 2.4.2 Secondary Research and Source Review
    • 2.4.3 Top-Down and Bottom-Up Estimation
    • 2.4.4 Data Triangulation and Verification
  • 2.5 Market Size Measurement Basis
    • 2.5.1 2024: USD 2.92 billion → 2032: USD 16.4 billion
  • 2.6 Historical and Forecast Reference Periods
    • 2.6.1 Base Year: 2024
    • 2.6.2 Forecast Period: 2024-2032
  • 2.7 Research Assumptions and Limitations

Chapter 3 Executive Summary

  • 3.1 Market Snapshot and Key Findings
  • 3.2 Base-Year Market Size, 2024
  • 3.3 Forecast Market Size, 2032
  • 3.4 Revenue and Volume Growth Outlook
  • 3.5 Key Demand and Supply Indicators
  • 3.6 Leading Market Segments
  • 3.7 Fastest-Growing Market Opportunities
  • 3.8 Regional Performance Highlights
  • 3.9 Technology and Industry Transformation
  • 3.10 Competitive Landscape Summary
  • 3.11 Analyst View and Strategic Implications

Chapter 4 Global Healthcare Fraud Analytics Market Trends and Developments

  • 4.1 Historical Industry Development
  • 4.2 Recent Market Trends and Developments
  • 4.3 Demand and Customer Behavior Trends
  • 4.4 Technology and Product Innovation
  • 4.5 Artificial Intelligence, Automation and Digitalization
  • 4.6 Local Manufacturing and Supply Chain Realignment
  • 4.7 Industry Partnerships, Mergers and Acquisitions
  • 4.8 Sustainability and Circular Economy Developments
  • 4.9 Government and Private Sector Investment Trends
  • 4.10 Emerging Business Models and Commercialization
  • 4.11 Industry Developments and Announcements

Chapter 5 Global Healthcare Fraud Analytics Market Supply and Demand Analysis

  • 5.1 Demand Trend and Consumption Analysis
  • 5.2 Demand Forecast, 2024-2032
  • 5.3 Supply Chain Structure and Procurement Trends
  • 5.4 Supply-Demand Gap and Bottlenecks
  • 5.5 Import Dependence and Sourcing Structure
  • 5.6 Regional Supply and Demand Concentration

Chapter 6 Global Healthcare Fraud Analytics Market Pricing Analysis

  • 6.1 Pricing Structure and Measurement
  • 6.2 Historical Pricing Trends
  • 6.3 Pricing Outlook, 2024-2032
  • 6.4 Pricing by Product and Market Segment
  • 6.5 Geographic Pricing Differences
  • 6.6 Key Input, Energy, Labor and Logistics Costs
  • 6.7 Contract Pricing and Purchasing Models
  • 6.8 Pricing Sensitivity and Competitive Positioning
  • 6.9 Price, Margin and Profitability Implications

Chapter 7 Global Healthcare Fraud Analytics Market Dynamics

  • 7.1 Market Growth Drivers
    • 7.1.1 Demand-Side Drivers
    • 7.1.2 Technology and Innovation Drivers
    • 7.1.3 Infrastructure and Investment Drivers
    • 7.1.4 Regulatory and Policy Drivers
  • 7.2 Market Restraints
    • 7.2.1 Cost and Affordability Constraints
    • 7.2.2 Technology and Adoption Barriers
    • 7.2.3 Supply Chain and Operational Constraints
  • 7.3 Market Challenges
    • 7.3.1 Competitive Pressure and Margin Erosion
    • 7.3.2 Skills, Infrastructure and Implementation Gaps
  • 7.4 Emerging Market Opportunities
  • 7.5 Market Dynamics Impact and Time-Horizon Assessment

Chapter 8 Global Healthcare Fraud Analytics Value Chain Analysis

  • 8.1 Industry Value Chain Overview
  • 8.2 Upstream Suppliers and Critical Inputs
  • 8.3 Technology and Component Providers
  • 8.4 Manufacturing or Service Delivery
  • 8.5 Distribution, Channel Partners and Integrators
  • 8.6 Downstream Applications and End Users
  • 8.7 Value Addition and Profit Pools
  • 8.8 Vertical Integration and Outsourcing
  • 8.9 Supplier Concentration and Risk
  • 8.10 Supply Chain Localization and Resilience

Chapter 9 Global Healthcare Fraud Analytics Market Regulations and Policies

  • 9.1 Relevant Laws, Standards and Compliance Frameworks
  • 9.2 Product, Service, Safety and Quality Requirements
  • 9.3 Government Policies, Incentives and Subsidies
  • 9.4 Imports, Exports and Trade Barriers
  • 9.5 Public Procurement and Local Content Requirements
  • 9.6 Data Protection, AI and Cybersecurity Compliance
  • 9.7 Upcoming Policy Changes and Market Implications

Chapter 10 Global Healthcare Fraud Analytics Market Hotspots and Opportunities

  • 10.1 Market Opportunity Mapping and Growth Hotspots
  • 10.2 High-Growth Applications and Customer Groups
  • 10.3 Underserved Markets and White-Space Opportunities
  • 10.4 Emerging Technology and Product Opportunities
  • 10.5 New Capacity and Investment Hotspots
  • 10.6 Market Entry and Expansion Opportunities
  • 10.7 Distribution and Partnership Opportunities
  • 10.8 Near-Term and Long-Term Commercial Potential
  • 10.9 Opportunity Attractiveness and Execution Risks

Chapter 11 Global Healthcare Fraud Analytics Market Outlook, 2024-2032

  • 11.1 Market Size and Analysis
    • 11.1.1 Revenue (Market Measurement: 2024: USD 2.92 billion → 2032: USD 16.4 billion)
    • 11.1.2 Historical Market Size
    • 11.1.3 Base-Year Market Size, 2024
  • 11.2 Market Forecast, 2024-2032
    • 11.2.1 Revenue Forecast to 2032
    • 11.2.2 CAGR and Year-on-Year Growth
    • 11.2.3 Incremental Revenue Opportunity
  • 11.3 Forecast Assumptions and Scenario Analysis
    • 11.3.1 Base-Case Forecast
    • 11.3.2 Optimistic and Conservative Scenarios
    • 11.3.3 Technology, Pricing and Policy Sensitivities
  • 11.4 Market Attractiveness and Growth Outlook

Chapter 12 Global Healthcare Fraud Analytics Market Segmentation and Outlook

  • 12.1 Segmentation Summary and Market Shares, 2024
  • 12.2 Largest and Fastest-Growing Segments
  • 12.3 By Application - Market Size and Forecast, 2024-2032
    • 12.3.1 Segment Definition and Scope
    • 12.3.2 Historical Market Size
    • 12.3.3 Revenue Forecast, 2024-2032
    • 12.3.4 Base-Year Market Share, 2024
    • 12.3.5 Segment CAGR and Growth Drivers
    • 12.3.6 Subsegment Market Size and Forecast
      • 12.3.6.1 Insurance claims review
      • 12.3.6.2 Pharmacy billing issue
      • 12.3.6.3 Payment integrity
      • 12.3.6.4 Other applications
    • 12.3.7 Subsegment Pricing and Adoption Trends
    • 12.3.8 Leading Suppliers and Competition
    • 12.3.9 Regional Demand and Opportunities
  • 12.4 By Solution Type - Market Size and Forecast, 2024-2032
    • 12.4.1 Segment Definition and Scope
    • 12.4.2 Historical Market Size
    • 12.4.3 Revenue Forecast, 2024-2032
    • 12.4.4 Base-Year Market Share, 2024
    • 12.4.5 Segment CAGR and Growth Drivers
    • 12.4.6 Subsegment Market Size and Forecast
      • 12.4.6.1 Descriptive analytics
      • 12.4.6.2 Predictive analytics
      • 12.4.6.3 Prescriptive analytics
    • 12.4.7 Subsegment Pricing and Adoption Trends
    • 12.4.8 Leading Suppliers and Competition
    • 12.4.9 Regional Demand and Opportunities
  • 12.5 By Deployment Mode - Market Size and Forecast, 2024-2032
    • 12.5.1 Segment Definition and Scope
    • 12.5.2 Historical Market Size
    • 12.5.3 Revenue Forecast, 2024-2032
    • 12.5.4 Base-Year Market Share, 2024
    • 12.5.5 Segment CAGR and Growth Drivers
    • 12.5.6 Subsegment Market Size and Forecast
      • 12.5.6.1 Cloud-based
      • 12.5.6.2 On-premises
    • 12.5.7 Subsegment Pricing and Adoption Trends
    • 12.5.8 Leading Suppliers and Competition
    • 12.5.9 Regional Demand and Opportunities
  • 12.6 Segment Growth Comparison
  • 12.7 Segment Attractiveness and Priority Matrix

Chapter 13 Global Healthcare Fraud Analytics End-Use and Application Market Outlook

  • 13.1 End-Use Industry and Customer Demand Structure
  • 13.2 Leading Applications and Customer Groups
  • 13.3 End-Use Market Size, Share and Forecast
  • 13.4 Major End-Use Industry Deep Dives
    • 13.4.1 Customer Requirements and Use Cases
    • 13.4.2 Demand and Replacement Cycles
    • 13.4.3 Technical and Regulatory Considerations
    • 13.4.4 Purchasing and Procurement Models
    • 13.4.5 Leading Vendors and Distribution Channels
    • 13.4.6 Forecast and Commercial Opportunities
  • 13.5 Emerging Applications and Cross-Segment Demand
  • 13.6 End-Use Industry Investment Priorities

Chapter 14 Global Healthcare Fraud Analytics Geographic Market Outlook, 2024-2032

  • 14.1 Regional Market Size and Share, 2024
  • 14.2 Regional Market Forecast, 2024-2032
  • 14.3 Regional Pricing, Production and Demand Differences
  • 14.4 North America
    • 14.4.1 United States
    • 14.4.2 Canada
    • 14.4.3 Mexico
  • 14.5 Europe
    • 14.5.1 Germany
    • 14.5.2 France
    • 14.5.3 Italy
    • 14.5.4 United Kingdom
    • 14.5.5 Spain
    • 14.5.6 Poland
    • 14.5.7 Russia
    • 14.5.8 Netherlands
    • 14.5.9 Belgium
    • 14.5.10 Sweden
    • 14.5.11 Denmark
    • 14.5.12 Norway
    • 14.5.13 Rest of Europe
  • 14.6 Asia Pacific
    • 14.6.1 China
    • 14.6.2 India
    • 14.6.3 Japan
    • 14.6.4 South Korea
    • 14.6.5 Thailand
    • 14.6.6 Indonesia
    • 14.6.7 Vietnam
    • 14.6.8 Malaysia
    • 14.6.9 Australia
    • 14.6.10 Rest of Asia Pacific
  • 14.7 Latin America
    • 14.7.1 Brazil
    • 14.7.2 Argentina
    • 14.7.3 Colombia
    • 14.7.4 Chile
    • 14.7.5 Rest of Latin America
  • 14.8 Middle East
    • 14.8.1 Saudi Arabia
    • 14.8.2 United Arab Emirates
    • 14.8.3 Turkey
    • 14.8.4 Israel
    • 14.8.5 Iran
    • 14.8.6 Rest of the Middle East
  • 14.9 Africa
    • 14.9.1 South Africa
    • 14.9.2 Egypt
    • 14.9.3 Nigeria
    • 14.9.4 Morocco
    • 14.9.5 Rest of Africa
  • 14.10 Regional Investment, Policy and Supply Chain Differences
  • 14.11 Regional Competitive Landscape
  • 14.12 Geographic Growth Hotspots

Chapter 15 Global Healthcare Fraud Analytics Technology, Innovation and Sustainability Outlook

  • 15.1 Technology Landscape and Maturity
  • 15.2 Product, Process and Service Innovation
  • 15.3 AI, Automation and Digital Tools in the Industry
  • 15.4 Technology Adoption and Performance Benchmarking
  • 15.5 Innovation Pipeline and R&D Investment
  • 15.6 Patent and Intellectual Property Trends
  • 15.7 Energy Efficiency and Resource Management
  • 15.8 Sustainability, Recycling and Circularity
  • 15.9 Technology Roadmap, 2024-2032
  • 15.10 Risks of Obsolescence and Technology Substitution

Chapter 16 Global Healthcare Fraud Analytics Market Key Strategic Imperatives

  • 16.1 Growth and Market Entry Priorities
  • 16.2 High-Return Products and Segments
  • 16.3 Pricing, Profitability and Cost Optimization
  • 16.4 Technology Investment and Product Differentiation
  • 16.5 Supply Chain Localization and Resilience
  • 16.6 Distribution and Customer Acquisition
  • 16.7 Partnership, Acquisition and Capacity Strategy
  • 16.8 Regional Expansion Priorities
  • 16.9 Short-, Medium- and Long-Term Actions

Chapter 17 Competition Outlook

  • 17.1 Industry Competition Characteristics
  • 17.2 Market Structure and Concentration
  • 17.3 Market Share and Competitive Positioning, 2024
  • 17.4 Company-Wise Revenue and Product Benchmarking
  • 17.5 Production and Service Capacity Benchmarking
  • 17.6 Technology, Pricing and Differentiation
  • 17.7 Regional Footprint and Distribution Strength
  • 17.8 Mergers, Acquisitions and Strategic Alliances
  • 17.9 New Entrants and Competitive Threats
  • 17.10 Porter's Five Forces and Industry Attractiveness
  • 17.11 Competitive Outlook, 2024-2032

Chapter 18 Company Profiles

  • 18.1 Company Coverage and Selection Criteria
  • 18.2 Conduent, Inc
    • 18.2.1 Business Description
    • 18.2.2 Company Ownership and Geographic Presence
    • 18.2.3 Product and Service Portfolio
    • 18.2.4 Manufacturing and Operating Footprint
    • 18.2.5 Financial Performance and Investment
    • 18.2.6 Market Share and Competitive Position
    • 18.2.7 Technology and Innovation Capabilities
    • 18.2.8 Strategic Alliances or Partnerships
    • 18.2.9 Recent Developments
    • 18.2.10 Growth Strategy and Outlook
  • 18.3 SAS Institute, Inc
  • 18.4 Kyndryl
  • 18.5 Optum, Inc
  • 18.6 Wipro Limited
  • 18.7 Cotiviti, Inc
  • 18.8 EXL Service Holdings, Inc
  • 18.9 HCL Technologies Limited
  • 18.10 IBM
  • 18.11 DXC Technology
  • 18.12 Other Relevant Market Participants

Note: Every listed company is profiled on the structure shown under the first company. The company list is preliminary and may change based on research findings, market developments, data availability and client requirements.

Chapter 19 Disclaimer

  • 19.1 Research and Forecast Disclaimer
  • 19.2 Data Source and Estimation Limitations

Note: The depth of individual sections depends on data availability for this market. Volume, capacity, trade and other unit-based metrics are included where applicable.

Methodology

Meet the Team

Dr. Pankaj Sharma
Dr. Pankaj Sharma

Healthcare Domain Expert & Medical Advisor

Dr. Pankaj Sharma is an anesthesiologist and healthcare strategic advisor who reviews epidemiological models, therapeutic market assessments and clinical assumptions at Credence Research Inc, so that quantitative forecasts reflect clinical realities.

Deepti Agrawal

Reviewed by

Deepti Agrawal

Head of Editorial Operations

Related Topics

Europe Electronic Medical Record (EMR) Market Size, Share, Growth and Forecast, 2025-2035

Europe electronic medical record (EMR) market worth USD 10.25 billion in 2025 will reach USD 18.01 billion by 2035 at a 5.80% CAGR as EHDS rules drive upgrades.

UAE Medical Tourism Market Size, Share, Growth and Forecast, 2025-2035

UAE medical tourism worth USD 382.8 million in 2025 dips in 2026, then reaches USD 740.0 million by 2035 at a 10.30% CAGR as Gulf and Asian patients return

Asia Pacific Drug Development Market Size, Share, Growth and Forecast, 2025-2035

Asia Pacific drug development market worth USD 50.29 billion in 2025 reaches USD 95.38 billion by 2035 at a 6.58% CAGR as biologics pipelines grow.

India Single Specialty Hospitals and Clinics Market Size, Share, Growth and Forecast, 2025-2035

India single specialty hospitals and clinics market worth USD 4.39 billion in 2025 is set to reach USD 31.46 billion by 2035 at a 21.63% CAGR as chains expand.

Egypt AI in Healthcare Diagnostics Market Size, Share, Growth and Forecast, 2025-2035

Egypt AI in healthcare diagnostics market worth USD 13.8 million in 2025 will reach USD 294.9 million by 2035 at a 35.83% CAGR as insured care expands.

India Gene Therapy Market Size, Share, Growth and Forecast, 2025-2035

India gene therapy market worth USD 63.5 million in 2025 is set to reach USD 1.12 billion by 2035 at a 32.19% CAGR as domestic CAR-T scales.